Shinichiro Nishishita - Sosei Group VP Disclosures

All Insiders . USA . 
Stock . Sosei Group . Stakeholders . Insider . Shinichiro Nishishita
SOLTF Stock  USD 8.05  0.00  0.00%   

Insider

Shinichiro Nishishita is VP Disclosures of Sosei Group
Phone81 3 5210 3290
Webhttps://soseiheptares.com

Sosei Group Management Efficiency

The company has return on total asset (ROA) of 0.0714 % which means that it generated a profit of $0.0714 on every $100 spent on assets. This is way below average. Sosei Group's management efficiency ratios could be used to measure how well Sosei Group manages its routine affairs as well as how well it operates its assets and liabilities.
Sosei Group has accumulated 27.44 B in total debt with debt to equity ratio (D/E) of 0.53, which is about average as compared to similar companies. Sosei Group has a current ratio of 19.99, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Sosei Group until it has trouble settling it off, either with new capital or with free cash flow. So, Sosei Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sosei Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sosei to invest in growth at high rates of return. When we think about Sosei Group's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Shengfei FangImmutep Ltd ADR
N/A
Wolfgang MDRigel Pharmaceuticals
58
Daniel CalkinsVerastem
36
Joseph FerraElevation Oncology
49
Brian SullivanElevation Oncology
N/A
Jonathan PachterVerastem
66
Mba MBAVerastem
70
Valerie MDElevation Oncology
46
Erin CoxVerastem
N/A
Ryan BloomerElevation Oncology
N/A
RPh PharmDElevation Oncology
40
Michelle MDVerastem
48
BPHARM RPhVerastem
63
Piyush GuptaVerastem
N/A
Christian MuellerImmutep Ltd ADR
N/A
Stephen JDGeron
74
Sean FlynnVerastem
50
David DornanElevation Oncology
46
Robert WeinbergVerastem
N/A
Sosei Group Corporation develops biopharmaceutical products worldwide. The company was incorporated in 1990 and is headquartered in Tokyo, Japan. Sosei operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 205 people. Sosei Group [SOLTF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Return On Equity-0.007
Return On Asset0.0714

Sosei Group Leadership Team

Elected by the shareholders, the Sosei Group's board of directors comprises two types of representatives: Sosei Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sosei. The board's role is to monitor Sosei Group's management team and ensure that shareholders' interests are well served. Sosei Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sosei Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
Candelle Chong, VP Communications
Chris Cargill, President, Officer
Stacey Southall, Associate Biophysics
Shinichiro Nishishita, VP Disclosures
Shinichi Tamura, CEO and President Representative Executive Officer, Director and Member of Nomination Committee
Kieran FCA, VP Officer
Miles Congreve, Chief Officer
Kazuhiko Yoshizumi, VP Officer
Hironoshin Nomura, VP Relations
Barry Kenny, Chief Devel

Sosei Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sosei Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.007
Return On Asset0.0714
Profit Margin(0.02) %
Operating Margin0.46 %
Current Valuation958.29 M
Shares Outstanding81.92 M
Shares Owned By Insiders12.05 %
Shares Owned By Institutions26.29 %
Price To Earning66.82 X
Price To Book2.36 X

Currently Active Assets on Macroaxis

VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C
MSFTMicrosoft
GMGeneral Motors

Other Information on Investing in Sosei Pink Sheet

Sosei Group financial ratios help investors to determine whether Sosei Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sosei with respect to the benefits of owning Sosei Group security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY